1) Guideline for risks and prevention of sudden cardiac death (JCS 2005). J Cardiol 48:411-423, 2006
2) Aizawa Y, Chinushi M, Washizuka T:Indications for an implantable cardioverter defibrillator (ICD). Internal Med 43:360-367, 2004
3) Connolly SJ, Hallstrom AP, Cappato R, et al:Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 21:2071-2078, 2000
4) Doval HC, Nul DR, Grancelli HO, et al:Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 344:493-498, 1994
5) Singh SN, Fletcher RD, Fisher SG, et al:Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med 333:77-82, 1995
6) Gomes JA, Winters SL, Martinson M, et al:The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats:a prospective study. J Am Coll Cardiol 13:377-384, 1998
7) Moss AJ, Hall WJ, Cannom DS, et al:for the multicenter automatic defibrillator implantation trial (MADIT) investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933-1940, 1996
8) Buxton AE, Lee KL, Fisher JD, et al:A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882-1890, 1999
9) Brugada P, Brugada J, Mont L, et al:A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 83:1649-1659, 1991